T
Thomas P. Davis
Researcher at University of Queensland
Publications - 761
Citations - 46194
Thomas P. Davis is an academic researcher from University of Queensland. The author has contributed to research in topics: Polymerization & Chain transfer. The author has an hindex of 107, co-authored 724 publications receiving 41495 citations. Previous affiliations of Thomas P. Davis include Commonwealth Scientific and Industrial Research Organisation & Federal University of Rio de Janeiro.
Papers
More filters
Journal ArticleDOI
Amidine functionality as a stimulus-responsive building block
TL;DR: This mini-review describes basic features and applications of small molecules and macromolecules containing amidine, and to a lesser extent, guanidine functional groups and demonstrates their application in areas ranging from reversible emulsion stabilization, purification and reversible self-assembly of polymeric nanoparticles.
Journal ArticleDOI
RAFT Synthesis and DNA Binding of Biodegradable, Hyperbranched Poly(2-(dimethylamino)ethyl Methacrylate
Journal ArticleDOI
Mitigation of Amyloidosis with Nanomaterials
Pu Chun Ke,Emily H. Pilkington,Yunxiang Sun,Yunxiang Sun,Ibrahim Javed,Aleksandr Kakinen,Guotao Peng,Feng Ding,Thomas P. Davis,Thomas P. Davis +9 more
TL;DR: The mechanisms underpinning protein aggregation and toxicity are introduced, and opportunities in materials science to drive this interdisciplinary field forward are highlighted.
Journal ArticleDOI
Access to Chain Length Dependent Termination Rate Coefficients of Methyl Acrylate via Reversible Addition−Fragmentation Chain Transfer Polymerization
Alexander Theis,Achim Feldermann,Nathalie Charton,Martina H. Stenzel,Thomas P. Davis,Christopher Barner-Kowollik +5 more
TL;DR: In this paper, the chain length dependency of the termination rate coefficient was constructed in a stepwise fashion since the MA/MCEPDA system displays hybrid behavior (between conventional and living free radical polymerization), resulting in initial high molecular weight polymers formed at low RAFT agent concentrations.
Journal ArticleDOI
A pH-responsive nanoparticle targets the neurokinin 1 receptor in endosomes to prevent chronic pain.
Paulina D. Ramírez-García,Paulina D. Ramírez-García,Jeffri S. Retamal,Jeffri S. Retamal,P.A. Shenoy,P.A. Shenoy,Wendy L. Imlach,Matthew J. Sykes,Nghia P. Truong,Nghia P. Truong,Luis Constandil,Teresa Pelissier,Cameron J. Nowell,Song Y. Khor,Song Y. Khor,Louis M. Layani,Louis M. Layani,Chris Lumb,Chris Lumb,Daniel P. Poole,Daniel P. Poole,Tina Marie Lieu,Tina Marie Lieu,Gregory D. Stewart,Quynh N. Mai,Quynh N. Mai,Dane D. Jensen,Rocco Latorre,Nicole N. Scheff,Brian L. Schmidt,John F. Quinn,John F. Quinn,Michael R. Whittaker,Michael R. Whittaker,Nicholas A. Veldhuis,Nicholas A. Veldhuis,Thomas P. Davis,Thomas P. Davis,Thomas P. Davis,Nigel W. Bunnett +39 more
TL;DR: Following intrathecal injection into rodents, the nanoparticles, containing the FDA-approved NK1R antagonist aprepitant, inhibit SP-induced activation of spinal neurons and thus prevent pain transmission and offers a much-needed non-opioid treatment option for chronic pain.